Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J1TS
|
||||
Former ID |
DCL000462
|
||||
Drug Name |
AZD2207
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes; Obesity [ICD9: 250, 278; ICD10:E08-E13, E66] | Discontinued in Phase 2 | [548462] | ||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H22Cl2F2N4O3+2
|
||||
Canonical SMILES |
CC(C1=CC(=CC=C1)Cl)NC(=O)CC2=C(C=CC(=[N+]2O)NCC(C3=CC=C<br />C=[N+]3O)(F)F)Cl
|
||||
InChI |
1S/C22H20Cl2F2N4O3/c1-14(15-5-4-6-16(23)11-15)28-21(31)12-18-17(24)8-9-20(30(18)33)27-13-22(25,26)19-7-2-3-10-29(19)32/h2-11,14,33H,12-13H2,1H3,(H-,28,31,32)/p+2/t14-/m1/s1
|
||||
InChIKey |
GNYWBETUYIZBHL-CQSZACIVSA-P
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Antagonist | [550288], [551589] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.